Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis

Breast Cancer Research and Treatment

Volumn 132, Issue 1, 2012, Pages 97-108

  Ramamoorthy, Sivapriya ^a   Tufail, Rozina ^a   Hokayem, Jimmy El ^a   Jorda, Mercy ^a   Zhao, Wei ^a   Reis, Zizi ^a   Nawaz, Zafar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; E6 AP; Mammary tumorigenesis; Ubiquitin ligase

Indexed keywords

CYCLINE; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR B; PROTEIN E6; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CANCER INHIBITION; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPHOCYTIC INFILTRATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE SYSTEM PROCESSES; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; MUTATION, MISSENSE; RECEPTORS, PROGESTERONE; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84857923196     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1567-2     Document Type: Article

References (38)

1. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75(3):495-505 (Pubitemid 23335075)
2. Nawaz Z, Lonard DM, Smith CL, Lev-Lehman E, Tsai SY, Tsai MJ, O'Malley BW (1999) The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol Cell Biol 19(2):1182-1189 (Pubitemid 29046860)
3. Gao X, Mohsin SK, Gatalica Z, Fu G, Sharma P, Nawaz Z (2005) Decreased expression of e6-associated protein in breast and prostate carcinomas. Endocrinology 146(4):1707-1712 (Pubitemid 40396878)
4. Ramamoorthy S, Dhananjayan SC, Demayo FJ, Nawaz Z (2010) Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. Mol Endocrinol 24(11):2099-2113. doi:10.1210/me.2010-0116
5. Khan OY, Fu G, Ismail A, Srinivasan S, Cao X, Tu Y, Lu S, Nawaz Z (2006) Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol Endocrinol 20(3):544-559 (Pubitemid 43291207)
6. Huibregtse JM, Scheffner M, Howley PM (1993) Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol 13(8):4918-4927 (Pubitemid 23220397)
7. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 92(7):2563-2567
8. Huibregtse JM, Scheffner M, Beaudenon S, Howley PM (1995) A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci USA 92(11):5249
9. Kumar S, Kao WH, Howley PM (1997) Physical interaction between specific E2 and Hect E3 enzymes determines functional cooperativity. J Biol Chem 272(21):13548-13554 (Pubitemid 27224784)
10. Conzen SD (2008) Minireview: nuclear receptors and breast cancer. Mol Endocrinol 22(10):2215-2228. doi:10.1210/me.2007-0421
11. Hewitt SC, Harrell JC, Korach KS (2005) Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67:285-308. doi:10.1146/annurev.physiol.67.040403.115914 (Pubitemid 40404493)
12. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P (1986) Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 24(1):77-83 (Pubitemid 16047760)
13. Jeltsch JM, Krozowski Z, Quirin-Stricker C, Gronemeyer H, Simpson RJ, Garnier JM, Krust A, Jacob F, Chambon P (1986) Cloning of the chicken progesterone receptor. Proc Natl Acad Sci USA 83(15):5424-5428 (Pubitemid 16001235)
14. Murphy LC, Watson P (2002) Steroid receptors in human breast tumorigenesis and breast cancer progression. Biomed Pharmacother 56(2):65-77 (Pubitemid 34241560)
15. Dimri G, Band H, Band V (2005) Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res 7(4):171-179. doi:10.1186/bcr1275 (Pubitemid 40872783)
16. Fisher ER, Osborne CK, McGuire WL, Redmond C, Knight WA 3rd, Fisher B, Bannayan G, Walder A, Gregory EJ, Jacobsen A, Queen DM, Bennett DE, Ford HC (1981) Correlation of primary breast cancer histopathology and estrogen receptor content. Breast Cancer Res Treat 1(1):37-41 (Pubitemid 12179413)
17. Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A, Rosen EM, Furth PA (2008) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene 27(6):794-802. doi:10.1038/sj.onc. 1210674 (Pubitemid 351186312)
18. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM (2007) Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8(5):R76. doi:10.1186/gb-2007-8-5-r76
19. Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37(12):4669-4671 (Pubitemid 8239679)
20. Osborne CK, Fisher E, Redmond C, Knight WA, Yochmowitz MG, McGuire WL (1981) Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis. Adv Exp Med Biol 138:377-385
21. Kleinberg DL, Wood TL, Furth PA, Lee AV (2009) Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev 30(1):51-74. doi:10.1210/er.2008- 0022
22. Soyal S, Ismail PM, Li J, Mulac-Jericevic B, Conneely OM, Lydon JP (2002) Progesterone's role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Res 4(5):191-196 (Pubitemid 34918997)
23. Osborne CK, Yochmowitz MG, Knight WA 3rd, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46(12 Suppl):2884-2888 (Pubitemid 11205652)
24. Knight WA 3rd, Osborne CK, McGuire WL (1980) Hormone receptors in primary and advanced breast cancer. Clin Endocrinol Metab 9(2):361-368 (Pubitemid 10005347)
25. Tilli MT, Frech MS, Steed ME, Hruska KS, Johnson MD, Flaws JA, Furth PA (2003) Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma. Am J Pathol 163(5):1713-1719 (Pubitemid 37310001)
26. Howard B, Ashworth A (2006) Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet 2(8):e112. doi:10.1371/journal.pgen.0020112
27. Gao X, Loggie BW, Nawaz Z (2002) The roles of sex steroid receptor coregulators in cancer. Mol Cancer 1:7
28. Sivaraman L, Nawaz Z, Medina D, Conneely OM, O'Malley BW (2000) The dual function steroid receptor coactivator/ubiquitin protein-ligase integrator E6-AP is overexpressed in mouse mammary tumorigenesis. Breast Cancer Res Treat 62(3):185-195
29. Kerscher O, Felberbaum R, Hochstrasser M (2006) Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159-180. doi:10.1146/annurev.cellbio.22.010605.093503
30. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W (2003) Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302(5652):1972-1975 (Pubitemid 37523506)
31. Oda H, Kumar S, Howley PM (1999) Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proc Natl Acad Sci USA 96(17):9557-9562 (Pubitemid 29398769)
32. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429(6987):86-92 (Pubitemid 38620556)
33. Cooper B, Schneider S, Bohl J, Jiang Y, Beaudet A, Vande Pol S (2003) Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306(1):87-99 (Pubitemid 36293399)
34. Lange CA, Shen T, Horwitz KB (2000) Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97(3):1032-1037 (Pubitemid 30080807)
35. Nawaz Z, Lonard DM, Dennis AP, Smith CL, O'Malley BW (1999) Proteasome-dependent degradation of the human estrogen receptor. Proc Natl Acad Sci USA 96(5):1858-1862 (Pubitemid 29117832)
36. Nawaz Z, O'Malley BW (2004) Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18(3):493-499. doi:10.1210/me.2003-0388 (Pubitemid 38328197)
37. Fang S, Lorick KL, Jensen JP, Weissman AM (2003) RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin Cancer Biol 13(1):5-14 (Pubitemid 36269176)
38. Ohta T, Fukuda M (2004) Ubiquitin and breast cancer. Oncogene 23(11):2079-2088. doi:10.1038/sj.onc.1207371 (Pubitemid 38496737)